to evaluate whether the clinical utility of these measurements may be extended , sequential measurements of fpg and ghb were examined from 16 outpatients with niddm followed over periods of 12 successive weeks or longer , including intervals following cessation of prior therapy or initiation of new hypoglycemic therapy with glipizide .
C0011860
niddm
C0017642
glipizide